Stryker Corporation $SYK Shares Sold by F m Investments LLC

F m Investments LLC reduced its stake in shares of Stryker Corporation (NYSE:SYK) by 66.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,015 shares of the medical technology company’s stock after selling 17,853 shares during the period. F m Investments LLC’s holdings in Stryker were worth $3,169,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SYK. Corient Private Wealth LLC grew its position in Stryker by 104.4% during the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after purchasing an additional 1,146,998 shares during the period. Alliancebernstein L.P. grew its position in Stryker by 13.3% during the 3rd quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock worth $2,342,987,000 after purchasing an additional 741,542 shares during the period. Strive Asset Management LLC acquired a new stake in Stryker during the 3rd quarter worth about $227,389,000. Credit Agricole S A acquired a new stake in Stryker during the 3rd quarter worth about $194,045,000. Finally, Pictet Asset Management Holding SA grew its position in Stryker by 190.3% during the 4th quarter. Pictet Asset Management Holding SA now owns 466,256 shares of the medical technology company’s stock worth $163,878,000 after purchasing an additional 305,640 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have weighed in on SYK shares. Evercore set a $355.00 price target on Stryker in a research report on Friday, May 1st. UBS Group dropped their target price on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 17th. TD Cowen cut Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price on the stock. in a research report on Monday, January 26th. William Blair restated an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 target price on Stryker in a research report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Price Performance

NYSE:SYK opened at $285.49 on Friday. Stryker Corporation has a 52 week low of $284.95 and a 52 week high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $109.34 billion, a PE ratio of 33.04, a price-to-earnings-growth ratio of 1.80 and a beta of 0.80. The stock’s 50-day moving average price is $340.37 and its 200-day moving average price is $355.17.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same quarter last year, the business earned $2.84 earnings per share. Stryker’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.